Iziyobisi ze-Hypoglycemic
| CAT # | Igama lemveliso | Inkcazo |
| CPD0004 | Ertugliflozin | I-Ertugliflozin, ekwabizwa ngokuba yi-PF-04971729, inamandla kwaye ikhetha inhibitor ye-sodium exhomekeke kwi-glucose cotransporter 2 kunye nomgqatswa weklinikhi kunyango lwe-2 yesifo sikashukela. |
| CPDA0048 | Omarigliptin | I-Omarigliptin, eyaziwa ngokuba yi-MK-3102, inamandla kwaye ithatha ixesha elide i-DPP-4 inhibitor yonyango lweveki ye-2 yeswekile. |
| CPDA1089 | I-Retagliptin | I-Retagliptin, ekwabizwa ngokuba yi-SP-2086, yi-DPP-4 inhibitor enokuthi isetyenziswe kunyango lwe-Type 2 yeswekile. |
| CPDA0088 | I-Trelagliptin | I-Trelagliptin, ekwaziwa njenge-SYR-472, sisithinteli se-dipeptidyl peptidase-4 (DPP-4) esisebenza ixesha elide esiphuhliswa yi-Takeda kunyango lwe-2 seswekile (T2D). |
| CPDA2039 | ILinagliptin | I-Linagliptin, ekwabizwa ngokuba yi-BI-1356, yi-DPP-4 inhibitor ephuhliswe ngu-Boehringer Ingelheim kunyango lwe-type II yeswekile. |
| CPDA0100 | I-Sitagliptin | I-Sitagliptin (INN; ichongiwe ngaphambili njenge-MK-0431 kwaye ithengiswe phantsi kwegama lorhwebo i-Januvia) i-antihyperglycemic yomlomo (i-anti-diabetic drug) yeklasi ye-dipeptidyl peptidase-4 (DPP-4) inhibitor. |
| CPD0854 | LX-4211 | I-LX-4211 inamandla amabini e-SGLT2/1 inhibitor; Ii-Antidiabetic agents. |
| CPDA1553 | LX-2761 | I-LX2761 yi-inhibitor ye-SGLT1 esebenza kwingingqi enamandla kakhulu kwi-vitro kwaye ilibazise ukufakwa kwe-glucose emathunjini kwi-vivo ukuphucula ulawulo lwe-glycemic. |
